Is patient age associated with risk of malignancy in a ≥4 cm cytologically benign thyroid nodule?

Background: Current data regarding the risk of malignancy in a large thyroid nodule with benign fine-needle aspiration biopsy(FNAB) is conflicting. We investigated the impact of patient age on the risk of malignancy in nodules >= 4 cm with benign cytology. Methods: We performed a single-institution retrospective review of patients who underwent surgery from 07/2008-08/2019 for a cytologically benign thyroid nodule >= 4 cm. The relationship between malignant histopathology and patient and ultrasound features was assessed with multivariable logistic regression. Results: Of 474 nodules identified, 25(5.3%) were malignant on final pathology. In patients <55 years old, 21/273(7.7%) nodules were malignant, compared to 4/201(2.0%) in patients >= 55. Patient age >= 55 was independently associated with significantly lower risk of malignancy(OR:0.2,95%0:0.1-0.7,p = 0.011). Increasing nodule size >4 cm and high-risk ultrasound features were not associated with risk of malignancy(OR:1.0,95%CI:0.7-1.4,p = 0.980, and OR:9.6,95%CI:0.9-107.8,p = 0.066, respectively). Conclusions: Patients <55 years old are 3.7-fold more likely to have a falsely benign FNA biopsy in a nodule >= 4 cm. (C) 2020 Elsevier Inc. All rights reserved.